Finanzen von Nutriband Inc (NTRB)NTRBNutriband Inc

Nutriband Inc (NTRB) generates its revenue primarily from Sale of goods, which accounts for 100.0% of total sales, equivalent to $400.71K. Understanding this concentration is critical for investors evaluating how NTRB navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Nutriband Inc maintains a gross margin of 45.41%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -289.42%, while the net margin is -286.56%. These profitability ratios, combined with a Return on Equity (ROE) of -539.15%, provide a clear picture of how effectively NTRB converts its operational activities into shareholder value.

In the context of the broader market, NTRB competes directly with industry leaders such as XTNT and COCH. With a market capitalization of $56.72M, it holds a leading position in the sector. When comparing efficiency, NTRB's gross margin of 45.41% stands against XTNT's 57.88% and COCH's -445.10%. Such benchmarking helps identify whether Nutriband Inc is trading at a premium or discount relative to its financial performance.

Nutriband's total revenue for Q2 2026 was 622,452 USD, but it reported a net income of -24,814,503 USD, indicating severe losses. The gross margin has fluctuated, with the latest figure at 22.20%, down from 44.51% in Q4 2025, showing declining profitability.